niguldipine has been researched along with rs 17053 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, DJ; Clarke, DE; Daniels, DV; Ford, AP; Gever, JR; Jasper, JR; Lesnick, JD | 1 |
Li, MY; Tsai, KC; Xia, L | 1 |
Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
3 other study(ies) available for niguldipine and rs 17053
Article | Year |
---|---|
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
Topics: Adrenergic Agents; Animals; CHO Cells; Cloning, Molecular; Cricetinae; Humans; Inositol Phosphates; Radioligand Assay; Receptors, Adrenergic, alpha-1; Recombinant Proteins | 1997 |
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |